BSE filing, NSE: INDRAMEDCO. Summary written from the filing by ALFA Finder's alert engine.
Indraprastha Medical Corporation Ltd: key numbers
- Share price
- ₹314.20
- Market cap
- ₹2,880 Cr
- Revenue (annual)
- ₹1,483 Cr
- Net profit (annual)
- ₹183.6 Cr
- P/E (TTM)
- 15.3×Sector 51.1×
- Promoter holding
- 51.00%+0.00% QoQ
- FII holding
- 2.39%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Indraprastha Medical Corporation Ltd
All →Indraprastha Medical Corporation Board Meeting Date
Indraprastha Medical Corporation will hold a board meeting on 29 Oct 2026 to consider Q1 FY27 unaudited standalone financial results. The trading window is closed from 1 Oct to 31 Oct 2026.
Indraprastha Medical Corporation Annual General Meeting
Indraprastha Medical Corporation Ltd announced voting results for its AGM held on September 24, 2026. Shareholders approved a dividend of Rs. 4.00 per equity share.
- Value
- ₹36.67 Cr
Indraprastha Medical Corporation Annual General Meeting
Indraprastha Medical Corporation Limited held its 38th AGM on September 24, 2026. Shareholders considered resolutions including a Rs. 4.00 per share dividend declaration.
Indraprastha Medical Corporation Annual Report
Indraprastha Medical Corporation Limited has released its Annual Report for FY 2025-26. The 38th Annual General Meeting is scheduled for September 24, 2026.
Indraprastha Medical Corporation Annual General Meeting
Indraprastha Medical Corporation will hold its 38th AGM on September 24, 2026. The company has fixed September 18, 2026, as the record date for dividend and e-voting.
Indraprastha Medical Corporation Q1 FY27 Results: Net Profit ₹55.9 Cr, Up 8.5% YoY
Indraprastha Medical Corporation Ltd reported revenue from operations of ₹406.1 Cr (+11.2% YoY) and net profit of ₹55.9 Cr (+8.5% YoY) for Q1 FY27.
- Key figure
- Net profit ₹55.9 Cr · +8.5% YoY
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.